{
    "nct_id": "NCT04667585",
    "official_title": "Radiotherapy Dose De-escalation in HPV-Associated Cancers of the Oropharynx Using Metabolic Signature From Interim 18FDG-PET/CT",
    "inclusion_criteria": "* Histologic documentation of squamous cell carcinoma of the oropharynx with p16-positive immunohistochemical staining and/or positive HPV in situ hybridization (ISH) and/or positive HPV PCR\n* Stage I-III (AJCC 8th edition) with plan for concurrent chemotherapy per standard of care treatment\n* Zubrod/ECOG score of 0-1\n* Weight loss <10% in the 3 months prior to diagnosis\n* â‰¥ 18 years of age\n* No prior chemotherapy for their current cancer diagnosis\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Prior radiotherapy to the head and neck\n* Medical contraindications to radiation therapy\n* Absence of gross disease on imaging prior to beginning radiation therapy\n* Distant metastatic disease\n* Medical contraindication to PET/CT\n* History of active cancer other than non-melanoma skin cancer within the last 5 years",
    "miscellaneous_criteria": ""
}